Raymond March Archive

Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.

Politics Is Costing Lives by Delaying Right-to-Try Legislation

Upon deeper inspection, it seems the conventional arguments against right-to-try come up short.

Misdiagnosing Right-to-try Laws

Right-to-try laws only apply to terminally ill patients who have exhausted all other options.

Markets Provide Care for an Aging Population

Technological advancements continue to provide cheaper and more effective solutions for healthcare’s most difficult problems.

Medical Apps: Improving Healthcare on a Global Scale

Health apps use smartphone technology to provide medical assistance or access to medical professionals.

FDA Greenlights Testing ‘Ecstasy’ for PTSD Therapy

MDMA, more commonly called “ecstasy” or “Molly,” is an illicit substance often taken to induce euphoria. The Controlled Substance Act considers MDMA a Schedule 1 controlled substance, which has no known medicinal benefits and a high likelihood of abuse. Penalties for using or distributing MDMA are considerably high even for a Schedule 1 substance....
Read More »

New Blood-Pressure Guidelines Raise Concerns about Interest-Group Lobbying

On November 13, millions of Americans had high blood pressure for the first time. It wasn’t even Thanksgiving. That day the American College of Cardiology (ACC), working with the American Heart Association (AHA), released new guidelines regarding what constitutes high blood pressure. Since 2003, a reading below 140/90 was considered normal. Now, any blood...
Read More »

  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org